Skip to main content

Table 1 Demographics of treated patients

From: Oral Acetazolamide after Boston Keratoprosthesis in Stevens Johnson Syndrome

Pt. no.

Age at onset of SJS/TEN (years)

Inciting agent for SJS/TEN

Self-reported drug allergies

Time after surgery when acetazolamide started (months)

Presence of glaucoma drainage tube pre-acetazolamide

Time on acetazolamide (months)

Adverse reactions to acetazolamide

1

43

ibuprofen

NSAID

1 day

Y

10 days

Warmth and pruritis

2*

48

sulindac

NSAID

24

N

1

N

3

40

allopurinol, erythromycin, colchicine

same

9

Y

9

N

4

50

Not known

terfenadine

0

N

31

N

5

3

PCN

PCN, sulfa, erythromycin

5

N

1.5

N

6

36

Not known

PCN, cefazolin, erythromycin

2

Y

24

N

7

54

bupropion, atenolol

same

13

Y

30

N

8

25

Not known

NKDA

7

Y

24

N

9

13

aspirin, ibuprofen

same

0.75

Y

1.5

N

10

Not known

Not known

PCN, codeine

Not known

Not known

9

N

11

27

PCN

PCN, sulfa

2

Y

64

N

  1. *This patient received a Boston keratoprosthesis type I.
  2. PCN: penicillin; NSAID: nonsteroidal anti-inflammatory drug.